Aprepitant 80 mg

DRUG3 trials

Sponsors

Merck Sharp & Dohme LLC, University Hospital, Brest, Insel Gruppe AG, University Hospital Bern

Conditions

Aquagenic PruritusBariatric SurgeryChemotherapy Induced Nausea and VomitingMyeloproliferative DisorderPostoperative Nausea and Vomiting

Phase 3

A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208)

CompletedNCT01362530

Merck Sharp & Dohme LLCChemotherapy Induced Nausea and Vomiting

Start: 2011-09-13End: 2013-08-16Updated: 2018-09-25

Aprepitant Versus Hydroxyzine in Persistent Aquagenic Pruritus for Patients With Myeloproliferative Neoplasms

CompletedNCT03808805

University Hospital, BrestAquagenic Pruritus, Myeloproliferative Disorder

Start: 2019-04-16End: 2024-08-22Updated: 2025-12-03

Phase 4

Dual-dose Aprepitant to Reduce Postoperative Nausea and Vomiting After Laparoscopic Bariatric Surgery.

TerminatedNCT05189756

Insel Gruppe AG, University Hospital BernBariatric Surgery, Postoperative Nausea and Vomiting

Start: 2022-03-17End: 2025-02-20Updated: 2025-02-27

Related Papers

Rationale and design of the multicentric, double-blind, double-placebo, randomized trial APrepitant versus HYdroxyzine in association with cytoreductive treatments for patients with myeloproliferative neoplasia suffering from Persistent Aquagenic Pruritus. Trial acronym: APHYPAP

Trials2021-12-199 citations

Aprepitant for the prevention of chemotherapy‐induced nausea and vomiting in paediatric subjects: An analysis by age group

Pediatric Blood & Cancer2018-06-1210 citations

Randomized, placebo-controlled, phase III study of aprepitant in preventing chemotherapy-induced nausea and vomiting in children: Analysis by age group.

Journal of Clinical Oncology2016-05-201 citations

Aprepitant for the prevention of chemotherapy-induced nausea and vomiting in children: a randomised, double-blind, phase 3 trial.

2015-03-1262 citations

Aprepitant for preventing chemotherapy-induced nausea and vomiting (CINV) in children.

Journal of Clinical Oncology2014-05-20